Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Allen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Environmental Research and Public Health|July 27, 2024
Creating Family-Centred Support for Children with Developmental Disabilities in Africa: Examples of Local Community InterventionsRoy McConkey, Sally Allen, Chipo Mlambo, et al.
Journal of Geriatric Oncology|November 1, 2024
Providing early access to geriatric oncology services in a regional cancer centre - A two-year experience in the establishment of a Geriatric Oncology Nurse Navigator ModelSebastian Kang, Sally Allen, Amy Brown, et al.
Brain Communications|February 26, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosisRuben P A van Eijk, Frederik J Steyn, Mark R Janse van Mantgem, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Environmental Research and Public Health|July 27, 2024
Creating Family-Centred Support for Children with Developmental Disabilities in Africa: Examples of Local Community InterventionsRoy McConkey, Sally Allen, Chipo Mlambo, et al.
Journal of Geriatric Oncology|November 1, 2024
Providing early access to geriatric oncology services in a regional cancer centre - A two-year experience in the establishment of a Geriatric Oncology Nurse Navigator ModelSebastian Kang, Sally Allen, Amy Brown, et al.
Brain Communications|February 26, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosisRuben P A van Eijk, Frederik J Steyn, Mark R Janse van Mantgem, et al.
Pageof 1